Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nadja Jäkel"'
Autor:
Marcus Bauer, Nadja Jäkel, Andreas Wilfer, Anja Haak, Markus Eszlinger, Katalin Kelemen, Monika Haemmerle, Haifa Kathrin Al-Ali, Barbara Seliger, Claudia Wickenhauser
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTGenetic aberrations and immune escape are fundamental in MDS and CMML initiation and progression to sAML. Therefore, quantitative and spatial immune cell organization, expression of immune checkpoints (ICP), classical human leukocyte antigen
Externí odkaz:
https://doaj.org/article/d789636c13bc4b76ba0c87d2a1cef791
Autor:
Maik Haupt, Nadja Jäkel, Maria Wachsmuth, Michael Stadler, Dietrich Beelen, Juergen Finke, Nael Alakel, Philipp Hemmati, Stefan Schönland, Wolfgang Bethge, Gerald Wulf, Daniel Wolff, Johanna Maria Tischer, Eva Wagner-Drouet, Anna Brandt, Nicolaus Kröger, Vladan Vucinic, Ben-Niklas Bärmann, Monika Brüggemann, Cora Gromann, Carsten Müller-Tidow, Nicola Gökbuget, Lutz Mueller
Publikováno v:
HemaSphere, Vol 7, p e85305e4 (2023)
Externí odkaz:
https://doaj.org/article/07366d2930ca47bcb5fbec29c886e435
Autor:
Alice Diepers, Susann Schulze, Nadja Jäkel, Danny Misiak, Christina Zahn, Claudia Spohn, Regina Moeller, Dietrich Kämpfe, Maik Schwarz, Katrin Nerger, Bayram Edemir, Haifa Kathrin Al-Ali
Publikováno v:
HemaSphere, Vol 7, p e602412a (2023)
Externí odkaz:
https://doaj.org/article/182347e72ff94e7595d7ac32573a3965
Autor:
Juliane Grimm, Donjete Simnica, Nadja Jäkel, Lisa Paschold, Edith Willscher, Susann Schulze, Christine Dierks, Haifa Kathrin Al-Ali, Mascha Binder
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Hypomethylating agents (HMA) like azacitidine are licensed for the treatment of acute myeloid leukemia (AML) patients ineligible for allogeneic hematopoietic stem cell transplantation. Biomarker-driven identification of HMA-responsive patien
Externí odkaz:
https://doaj.org/article/1ce8b017093d45eba92be6a584b6ffac
Autor:
Thoralf Lange, Anja Edelmann, Udo Siebolts, Rainer Krahl, Claudia Nehring, Nadja Jäkel, Michael Cross, Jacqueline Maier, Dietger Niederwieser, Claudia Wickenhauser
Publikováno v:
Haematologica, Vol 98, Iss 5 (2013)
The risk profile and prognosis of patients with myelofibrosis is well described by the Dynamic International Prognostic Scoring System risk categorization. Allogeneic stem cell transplantation is considered for intermediate-2/high risk disease. Howev
Externí odkaz:
https://doaj.org/article/d877e4af67af4e2a88c24f6694acb97c
Autor:
Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke, Nadja Jäkel, Susann Schulze, Jeanett Edelmann, Kolja Nenoff, Nora Grieb, Veljko Jeremic, Michael Cross, Sabine Leiblein, Enrica Bach, Wolfram Pönisch, Haifa-Kathrin Al-Ali, Sebastian Schwind, Uwe Platzbecker, Thoralf Lange, Dietger Niederwieser, Vladan Vucinic
Publikováno v:
Bone Marrow Transplantation. 57:824-826
Autor:
Guy Leverger, Marie-Amelyne Le Rouzic, Christian Rose, Laila Hessissen, Nadja Jäkel, Bertrand Isidor, Stéphane Ducassou, Patrick Lutz, Sophie Bayart, Cyrielle Fouquet, Mony Fahd, Emmanuelle Bourrat, Marlène Pasquet, Fanny Fouyssac, Mohamed Touati, Isabelle Thuret, Thierry Leblanc, Christiane Vermylen, Ralf Knoefler, Sandrine Marlin, Thomas Matthes, Valerie Triolo, Emmanuel Raffoux, Jean-Pierre Vannier, Caroline Kannengiesser
Publikováno v:
British Journal of Haematology, Vol. 187, No 4 (2019) pp. 530-542
Congenital sideroblastic anaemia (CSA) is a rare disease caused by germline mutations of genes involved in haem and iron-sulphur cluster formation, and mitochondrial protein biosynthesis. We performed a retrospective multicentre European study of a c
Autor:
Jason Gotlib, Nadja Jäkel, Chiara Elena, Knut Brockow, Anna Belloni Fortina, Hanneke Oude Elberink, Alexander Avian, David Fuchs, Aleksandra Górska, Agnes Bretterklieber, Massimo Triggiani, Wolfgang R. Sperr, Elisabeth Aberer, Andreas Reiter, Nikolas von Bubnoff, Roberta Parente, Jens Panse, Bjorn van Anrooij, Francesca Caroppo, Peter Valent, Emir Hadzijusufovic, Michael Doubek, Magdalena Lange, Valeria Brazzelli, Patrizia Bonadonna, Anja Illerhaus, Marek Niedoszytko, Mohamad Jawhar, Hanneke C. Kluin-Nelemans, Vito Sabato, Karin Hartmann, Roberta Zanotti
Publikováno v:
Journal of Investigative Dermatology, 141(7), 1719-1727. ELSEVIER SCIENCE INC
The journal of investigative dermatology
The journal of investigative dermatology
Mastocytosis is a rare neoplasm characterized by the expansion and accumulation of mast cells in various organ systems. Systemic mastocytosis (SM) may or may not present with cutaneous lesions. To examine the frequency and clinical impact of cutaneou
Autor:
Jason Gotlib, Patrizia Bonadonna, Nadja Jäkel, Karoline V. Gleixner, Massimo Triggiani, Lucie Nekvindová, Luca Malcovati, Hanneke Oude Elberink, Akif Selim Yavuz, Mattias Mattsson, Roberta Parente, Andreas Reiter, Nikolas von Bubnoff, Karin Hartmann, Olivier Hermine, Roberta Zanotti, Michel Arock, Anja Illerhaus, Knut Brockow, Alexander Zink, Magdalena Lange, Massimiliano Bonifacio, Hanneke C. Kluin-Nelemans, Michael Doubek, Anna Belloni Fortina, Jiri Mayer, Alex Kilbertus, Khalid Shoumariyeh, Aleksandra Górska, Vito Sabato, Jens Panse, David Fuchs, Hans Hägglund, Wolfgang R. Sperr, Peter Valent, Chiara Elena, Bjorn van Anrooij, Marek Niedoszytko, Mohamad Jawhar, Francesca Caroppo, Cecelia Perkins, Jakub Trizuljak, Agnes Bretterklieber
Publikováno v:
Allergy: European journal of allergy and clinical immunology
Allergy, 75(8), 1927-1938. Wiley-Blackwell
Allergy
Allergy, 75(8), 1927-1938. Wiley-Blackwell
Allergy
Background: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable
Autor:
Thierry Leblanc, Hana Manceau, Fanny Fouyssac, J.F. Guichard, Nadja Jäkel, Patrick Lutz, Jean-Pierre Vannier, Cyrielle Fouquet, Fabienne Toutain, Mohamed Touati, Christiane Vermylen, Yves Perel, Marie-Amelyne Le Rouzic, Karim Maloum, Caroline Kannengiesser
Publikováno v:
Blood Cells, Molecules and Diseases
Blood Cells, Molecules and Diseases, Elsevier, 2017, 66, pp.11-18. ⟨10.1016/j.bcmd.2017.07.003⟩
Blood Cells, Molecules and Diseases, Elsevier, 2017, 66, pp.11-18. ⟨10.1016/j.bcmd.2017.07.003⟩
The most frequent germline mutations responsible for non syndromic congenital sideroblastic anemia are identified in ALAS2 and SLC25A38 genes. Iron overload is a key issue and optimal chelation therapy should be used to limit its adverse effects on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7055f283bc2dca6de4520ee81866810
https://hal.archives-ouvertes.fr/hal-02377918
https://hal.archives-ouvertes.fr/hal-02377918